Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Current Opinion in Lipidology
|
May 29, 2019
Inheritance of high and low HDL: mechanisms and management
Andreas Sourlas, Constantine E Kosmas
Current Medicinal Chemistry
|
July 16, 2021
Environmental Factors Modifying HDL Functionality
Constantine E Kosmas, Andreas Sourlas, Eliscer Guzman, et al.
World Journal of Cardiology
|
December 5, 2019
Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease
Constantine E Kosmas, Andreas Sourlas, Delia Silverio, et al.
Annals of Translational Medicine
|
January 4, 2019
Role of spironolactone in the treatment of heart failure with preserved ejection fraction
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Annals of Translational Medicine
|
September 27, 2019
Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects
Peter D Montan, Andreas Sourlas, Jiohanna Olivero, et al.
Drugs in Context
|
December 6, 2018
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Drugs in Context
|
September 15, 2018
Primary genetic disorders affecting high density lipoprotein (HDL)
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Drugs in Context
|
November 19, 2021
New and emerging lipid-modifying drugs to lower LDL cholesterol
Constantine E Kosmas, Dafni Pantou, Andreas Sourlas, et al.
Annals of Translational Medicine
|
June 4, 2019
Anti-inflammatory therapy for cardiovascular disease
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Annals of Translational Medicine
|
October 29, 2019
Role of lipoprotein (a) in peripheral arterial disease
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Current Opinion in Lipidology
|
May 29, 2019
Inheritance of high and low HDL: mechanisms and management
Andreas Sourlas, Constantine E Kosmas
Current Medicinal Chemistry
|
July 16, 2021
Environmental Factors Modifying HDL Functionality
Constantine E Kosmas, Andreas Sourlas, Eliscer Guzman, et al.
World Journal of Cardiology
|
December 5, 2019
Novel lipid-modifying therapies addressing unmet needs in cardiovascular disease
Constantine E Kosmas, Andreas Sourlas, Delia Silverio, et al.
Annals of Translational Medicine
|
January 4, 2019
Role of spironolactone in the treatment of heart failure with preserved ejection fraction
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Annals of Translational Medicine
|
September 27, 2019
Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects
Peter D Montan, Andreas Sourlas, Jiohanna Olivero, et al.
Drugs in Context
|
December 6, 2018
Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Drugs in Context
|
September 15, 2018
Primary genetic disorders affecting high density lipoprotein (HDL)
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Drugs in Context
|
November 19, 2021
New and emerging lipid-modifying drugs to lower LDL cholesterol
Constantine E Kosmas, Dafni Pantou, Andreas Sourlas, et al.
Annals of Translational Medicine
|
June 4, 2019
Anti-inflammatory therapy for cardiovascular disease
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Annals of Translational Medicine
|
October 29, 2019
Role of lipoprotein (a) in peripheral arterial disease
Constantine E Kosmas, Delia Silverio, Andreas Sourlas, et al.
Page
of 2